Pediatric-Onset Multiple Sclerosis (POMS)
4
1
1
0
Key Insights
Highlights
Treatment Research
17 treatments under study, led by Moderna Mrna1273
Related Conditions
Often studied with 9 related conditions
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
25.0%
1 terminated out of 4 trials
0.0%
-86.6% vs benchmark
0%
0 trials in Phase 3/4
0%
1 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (4)
COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders
Dual-Task Training in Pediatric Multiple Sclerosis
Comparison of Structured Exercise and Exergaming in Pediatric-Onset Multiple Sclerosis
Five Times Sit-To-Stand Test for Patients with Pediatric-Onset Multiple Sclerosis
Research Network
Common Treatments
- Moderna Mrna12731
- Continue Is Mmf Or Mpa1
- Continue Is Mtx1
- Monovalent B1351 Cov2 Pres Dtmas031
- Conventional Functional Exercise Training1
Active Sponsors
- Istanbul University - Cerrahpasa3
- Autoimmunity Centers of Excellence1
- Rho Federal Systems Division, Inc.1
- National Institute of Allergy and Infectious Diseases (NIAID)1
Top Investigators
Center of Autoimmune Musculoskeletal and Hematopoietic Diseases, Feinstein Institute for Medical Research
Istanbul University-Cerrahpasa Cerrahpasa Faculty of Medicine, Department of Pediatric Neurology
Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation
Center for Neuroinflammation and Neurotherapeutics, Perelman School of Medicine, University of Pennsylvania
Drukier Institute for Children's Health, Weill Cornell Medical College
Related Conditions
- Pediatric Sle1
- Pemphigus Vulgaris1
- Systemic Sclerosis Ssc1
- Multiple Sclerosis Ms1
- Systemic Lupus Erythematosus Sle1